Luke H Hoeppner (Luke Hoeppner)

Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 19

Top Topics

Epithelial Mesenchymal Transition

Epidermal Growth Factor Receptor

Small Cell Lung Cancer

Top Venues

NPJ precision oncology

Research square

British journal of cancer

This page only lists publications with an associated author ORCID identifier.

Publications

Marina G Ferrari, Alexis P Jimenez-Uribe, Li Wang, Luke H Hoeppner, Paari Murugan, Eunsil Hahm, Jindan Yu, Timothy M Kuzel, Sergio A Gradilone, Adrian P Mansini
Myeloid differentiation factor-2/LY96, a potential predictive biomarker of metastasis and poor outcomes in prostate cancer: clinical implications as a potential therapeutic target. Oncogene (2023)
Sk Kayum Alam, Li Wang, Zhu Zhu, Luke H Hoeppner
IKKα promotes lung adenocarcinoma growth through ERK signaling activation via DARPP-32-mediated inhibition of PP1 activity. NPJ precision oncology 7 (1) (2023)
Marina G Ferrari, Alexis P Jimenez-Uribe, Li Wang, Luke H Hoeppner, Paari Murugan, Eunsil Hahm, Jindan Yu, Timothy M Kuzel, Sergio A Gradilone, Adrian P Mansini
Myeloid differentiation factor-2/LY96, a potential predictive biomarker of metastasis and poor outcomes in prostate cancer: clinical implications as a potential therapeutic target. Oncogene 43 (7) (2023)
Marina G Ferrari, Alexis P Jimenez-Uribe, Li Wang, Luke H Hoeppner, Paari Murugan, Eunsil Hahm, Jindan Yu, Timothy M Kuzel, Sergio A Gradilone, Adrian P Mansini
Myeloid differentiation factor-2/LY96, a potential predictive biomarker of metastasis and poor outcomes in prostate cancer: clinical implications as a potential therapeutic target. Oncogene 43 (7) (2023)
Marina G Ferrari, Alexis P Jimenez-Uribe, Li Wang, Luke H Hoeppner, Paari Murugan, Eunsil Hahm, Jindan Yu, Timothy M Kuzel, Sergio A Gradilone, Adrian P Mansini
Myeloid differentiation factor-2/LY96, a potential predictive biomarker of metastasis and poor outcomes in prostate cancer: clinical implications as a potential therapeutic target. Oncogene 43 (7) (2023)
Marina G Ferrari, Alexis P Jimenez-Uribe, Li Wang, Luke H Hoeppner, Paari Murugan, Eunsil Hahm, Jindan Yu, Timothy M Kuzel, Sergio A Gradilone, Adrian P Mansini
Myeloid differentiation factor-2/LY96, a potential predictive biomarker of metastasis and poor outcomes in prostate cancer: clinical implications as a potential therapeutic target. Oncogene 43 (7) (2023)
Marina G Ferrari, Alexis P Jimenez-Uribe, Li Wang, Luke H Hoeppner, Paari Murugan, Eunsil Hahm, Jindan Yu, Timothy M Kuzel, Sergio A Gradilone, Adrian P Mansini
Myeloid differentiation factor-2/LY96, a potential predictive biomarker of metastasis and poor outcomes in prostate cancer: clinical implications as a potential therapeutic target. Oncogene 43 (7) (2023)
Marina G Ferrari, Alexis P Jimenez-Uribe, Li Wang, Luke H Hoeppner, Paari Murugan, Eunsil Hahm, Jindan Yu, Timothy M Kuzel, Sergio A Gradilone, Adrian P Mansini
Myeloid differentiation factor-2/LY96, a potential predictive biomarker of metastasis and poor outcomes in prostate cancer: clinical implications as a potential therapeutic target. Oncogene (2023)
Sk Kayum Alam, Li Wang, Zhu Zhu, Luke H Hoeppner
IKKα promotes lung adenocarcinoma growth through ERK signaling activation via DARPP-32-mediated inhibition of PP1 activity. NPJ precision oncology 7 (1) (2023)
Marina Ferrari, Li Wang, Luke H Hoeppner, Eunsil Hahm, Jindan Yu, Timothy Kuzel, Adrian P Mansini
Myeloid differentiation factor-2/LY96, a new predictive biomarker of metastasis in prostate cancer: Clinical implications as a potential therapeutic target. Research square (2023)
Sk Kayum Alam, Li Wang, Zhu Zhu, Luke H Hoeppner
IKKα promotes lung adenocarcinoma growth through ERK signaling activation via DARPP-32-mediated inhibition of PP1 activity. NPJ precision oncology 7 (1) (2023)
Marina G Ferrari, Alexis P Jimenez-Uribe, Li Wang, Luke H Hoeppner, Paari Murugan, Eunsil Hahm, Jindan Yu, Timothy M Kuzel, Sergio A Gradilone, Adrian P Mansini
Myeloid differentiation factor-2/LY96, a potential predictive biomarker of metastasis and poor outcomes in prostate cancer: clinical implications as a potential therapeutic target. Oncogene (2023)
Marina G Ferrari, Alexis P Jimenez-Uribe, Li Wang, Luke H Hoeppner, Paari Murugan, Eunsil Hahm, Jindan Yu, Timothy M Kuzel, Sergio A Gradilone, Adrian P Mansini
Myeloid differentiation factor-2/LY96, a potential predictive biomarker of metastasis and poor outcomes in prostate cancer: clinical implications as a potential therapeutic target. Oncogene 43 (7) (2023)
Kathryn N Phoenix, Zhichao Yue, Lixia Yue, Chunxia G Cronin, Bruce T Liang, Luke H Hoeppner, Kevin P Claffey
PLCβ2 Promotes VEGF-Induced Vascular Permeability. Arteriosclerosis, thrombosis, and vascular biology 42 (10) (2022)
Sk Kayum Alam, Yong-Chang Zhang, Li Wang, Zhu Zhu, Christina E Hernandez, Yuling Zhou, Nong Yang, Jian Lei, Xiaoyan Chen, Liang Zeng, Mark A Klein, Luke H Hoeppner
DARPP-32 promotes ERBB3-mediated resistance to molecular targeted therapy in EGFR-mutated lung adenocarcinoma. Oncogene (2021)
Helena Klara Jambor, Alberto Antonietti, Bradly Alicea, Tracy L Audisio, Susann Auer, Vivek Bhardwaj, Steven J Burgess, Iuliia Ferling, Małgorzata Anna Gazda, Luke H Hoeppner, Vinodh Ilangovan, Hung Lo, Mischa A Olson, Salem Yousef Mohamed, Sarvenaz Sarabipour, Aalok Varma, Kaivalya Walavalkar, Erin M Wissink, Tracey L Weissberger
Creating clear and informative image-based figures for scientific publications. PLoS biology 19 (3) (2021)
Li Wang, Matteo Astone, Sk Kayum Alam, Zhu Zhu, Wuhong Pei, David A Frank, Jason W Sinclair, Luke H Hoeppner
Suppressing STAT3 activity protects the endothelial barrier from VEGF-mediated vascular permeability. Disease models & mechanisms 14 (11) (2021)
Sk Kayum Alam, Li Wang, Yanan Ren, Christina E Hernandez, Farhad Kosari, Anja C Roden, Rendong Yang, Luke H Hoeppner
ASCL1-regulated DARPP-32 and t-DARPP stimulate small cell lung cancer growth and neuroendocrine tumour cell proliferation. British journal of cancer 123 (5) (2020)
Sk Kayum Alam, Matteo Astone, Ping Liu, Stephanie R Hall, Abbygail M Coyle, Erin N Dankert, Dane K Hoffman, Rui Kuang, Rui Kuang, Anja C Roden, Aaron S Mansfield, Luke H Hoeppner
DARPP-32 and t-DARPP promote non-small cell lung cancer growth through regulation of IKKα-dependent cell migration. Communications biology 1 (2018)